HS235 Study in Obese Participants With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)

HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction

NCT06391710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT05592275 ·Status: TERMINATED ·Phase: PHASE2

Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

NCT04210375 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.

NCT00050076 ·Status: COMPLETED ·Phase: PHASE2

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

NCT05322616 ·Status: WITHDRAWN ·Phase: PHASE1

A Study of CK-1827452 Infusion in Stable Heart Failure

NCT00624442 ·Status: COMPLETED ·Phase: PHASE2

Matching Perfusion and Metabolic Activity in HFpEF

NCT04913805 ·Status: RECRUITING ·Phase: PHASE2

Short-term Effects of Dapagliflozin on Peak VO2 in HFrEF

NCT04197635 ·Status: COMPLETED ·Phase: PHASE4

Study of Dapansutrile Capsules in Heart Failure

NCT03534297 ·Status: COMPLETED ·Phase: PHASE1

Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction

NCT04475042 ·Status: UNKNOWN ·Phase: PHASE2

Developing Oral LT3 Therapy for Heart Failure - HFpEF

NCT04111536 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Dapagliflozin in PRESERVED Ejection Fraction Heart Failure

NCT03030235 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction

NCT03875183 ·Status: UNKNOWN ·Phase: PHASE2

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

NCT06793371 ·Status: RECRUITING ·Phase: PHASE2

A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction

NCT02980068 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF

NCT02256345 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF)

NCT05328752 ·Status: COMPLETED ·Phase: PHASE1

Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure

NCT03387215 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Multiple Dose Study in Heart Failure of BAY 1067197

NCT02040233 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety of BMS-986259 in Participants With Post-Acute Decompensated Heart Failure

NCT04318093 ·Status: COMPLETED ·Phase: PHASE2

Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency

NCT00745316 ·Status: TERMINATED ·Phase: PHASE2

Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction

NCT01542502 ·Status: COMPLETED ·Phase: NA

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

NCT06991257 ·Status: RECRUITING ·Phase: PHASE2

A Randomized Trial of Udenafil Therapy in Patients With Heart Failure With Preserved Ejection Fraction [ULTIMATE-HFpEF]

NCT01599117 ·Status: UNKNOWN ·Phase: PHASE3

Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

NCT07147114 ·Status: RECRUITING ·Phase: PHASE4